Tissue Biomarkers in Prognostication of Serous Ovarian Cancer following Neoadjuvant Chemotherapy

Serous ovarian cancer (SOC) is a significant cause of morbidity and mortality in females with poor prognosis because of advanced stage at presentation. Recently, neoadjuvant chemotherapy (NACT) is being used for management of advanced SOC, but role of tissue biomarkers in prognostication following N...

Descripción completa

Detalles Bibliográficos
Autores principales: Khandakar, Binny, Mathur, Sandeep R., Kumar, Lalit, Kumar, Sunesh, Datta Gupta, Siddhartha, Iyer, Venkateswaran K., Kalaivani, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016870/
https://www.ncbi.nlm.nih.gov/pubmed/24864239
http://dx.doi.org/10.1155/2014/401245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016870/
https://www.ncbi.nlm.nih.gov/pubmed/24864239
http://dx.doi.org/10.1155/2014/401245

Ejemplares similares